Effect of Elaeagnus angustifolia on dyspepsia

Evaluation of the effect of Elaeagnus angustifolia on reducing the symptoms of dyspepsia in comparison with placebo in patients with functional dyspepsia.

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20221224056906N1

Enrollment

Registered

2023-02-13

Start date

2023-02-20

Completion date

Unknown

Last updated

2023-03-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional dyspepsia. Functional dyspepsia

Interventions

Intervention 1: intervention group : one omeprazole 20 mg capsule per day, plus one tablet containing Elaeagnus angustifolia product, three times after three meals, is prescribed for one month. Interv

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients referred to Khurshid Gastroenterology Clinic who are diagnosed with functional dyspepsia according to Rome IV criteria

Exclusion criteria

Exclusion criteria: Patient who have structural dyspepsia diseases (during endoscopic examination) They have recently taken digestive medicines

Design outcomes

Primary

Measure	Time frame
Average range of dyspepsia symptoms. Timepoint: before the intervention and 2 weeks after and 4 weeks after the start of the drug. Method of measurement: GSRS questionnaire (Gastrointestinal symptom rating scale).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Soheilipour

Esfahan University of Medical Sciences

vahid.z1395@gmail.com+98 31 5333 7848

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026